-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Reiterates Outperform on Arrowhead Pharma, Maintains $100 Price Target

Benzinga·08/31/2026 13:11:45
Listen to the news
RBC Capital analyst Luca Issi reiterates Arrowhead Pharma (NASDAQ:ARWR) with a Outperform and maintains $100 price target.